Anthracycline-induced Cardiac Toxicity More Likely in Underweight Childhood Cancer Survivors

被引:8
作者
Andolina, Jeffrey R. [1 ]
Dilley, Kimberley [1 ]
机构
[1] Childrens Mem Hosp, Chicago, IL 60614 USA
关键词
anthracycline; cancer survivor; cardiomyopathy; echocardiogram; underweight; CLINICAL HEART-FAILURE; BODY-MASS INDEX; DOXORUBICIN THERAPY; RISK-FACTORS; CARDIOTOXICITY; CHILDREN; COHORT; FREQUENCY;
D O I
10.1097/MPH.0b013e3181dccd37
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We did a retrospective medical record and echocardiogram review of patients with history of anthracyclines and/or radiation seen in a long-term survivor clinic from 2000-2007. Observations: Three hundred eight out of three hundred seventy (83.2%) patients had received at least 1 screening echocardiogram, and 24/308 (7.8%) patients had an abnormal echocardiogram. Observed risk factors for a future abnormal echocardiogram included anthracycline dose >= 250mg/m(2) and underweight status (BMI < 5th%) at follow-up. Age, gender, radiation, anthracycline type, history of relapse, and history of stem cell transplant were not risk factors. Conclusions: Our results confirm the dose-dependent risk of anthracyclines, and describe a novel association with underweight status.
引用
收藏
页码:411 / 415
页数:5
相关论文
共 19 条
[1]  
[Anonymous], 2006, SEER CANC STAT REV 1
[2]  
[Anonymous], 2008, Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers
[3]   Body-mass index and mortality in a prospective cohort of US adults [J].
Calle, EE ;
Thun, MJ ;
Petrelli, JM ;
Rodriguez, C ;
Heath, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) :1097-1105
[4]   Anthracycline-induced cardiomyopathy [J].
Keefe, DL .
SEMINARS IN ONCOLOGY, 2001, 28 (04) :2-7
[5]   Anthracycline cardiotoxicity in children [J].
Kremer, LCM ;
Caron, HN .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (02) :120-121
[6]   Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children:: a systematic review [J].
Kremer, LCM ;
van der Pal, HJH ;
Offringa, M ;
van Dalen, EC ;
Voûte, PA .
ANNALS OF ONCOLOGY, 2002, 13 (06) :819-829
[7]   Frequency and risk factors of anthracycline-induced clinical heart failure in children:: a systematic review [J].
Kremer, LCM ;
van Dalen, EC ;
Offringa, M ;
Voûte, PA .
ANNALS OF ONCOLOGY, 2002, 13 (04) :503-512
[8]   Anthracycline-induced clinical heart failure in a cohort of 607 children:: Long-term follow-up study [J].
Kremer, LCM ;
van Dalen, EC ;
Offringa, M ;
Ottenkamp, J ;
Voûte, PA .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :191-196
[9]   Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience [J].
Krischer, JP ;
Epstein, S ;
Cuthbertson, DD ;
Goorin, AM ;
Epstein, ML ;
Lipshultz, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1544-1552
[10]   Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia [J].
Lipshultz, SE ;
Lipsitz, SR ;
Sallan, SE ;
Dalton, VM ;
Mone, SM ;
Gelber, RD ;
Colan, SD .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2629-2636